Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #49,501 to #49,550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Primary amoebic meningoencephalitis cost-effectiveness of therapy (3 revisions)
  2. Primary amoebic meningoencephalitis imaging findings (3 revisions)
  3. Primary amoebic meningoencephalitis other diagnostic studies (3 revisions)
  4. Primary amyloidosis MRI (3 revisions)
  5. Primary amyloidosis causes (3 revisions)
  6. Primary amyloidosis other imaging findings (3 revisions)
  7. Primary amyloidosis risk factors (3 revisions)
  8. Primary central nervous system lymphoma Secondary Prevention (3 revisions)
  9. Primary central nervous system lymphoma case study one (3 revisions)
  10. Primary central nervous system lymphoma chest x ray (3 revisions)
  11. Primary central nervous system lymphoma echocardiography or ultrasound (3 revisions)
  12. Primary central nervous system lymphoma primary prevention (3 revisions)
  13. Primary central nervous system lymphoma secondary prevention (3 revisions)
  14. Primary ciliary dyskinesia cost-effectiveness of therapy (3 revisions)
  15. Primary ciliary dyskinesia future or investigational therapies (3 revisions)
  16. Primary ciliary dyskinesia interventions (3 revisions)
  17. Primary cutaneous follicle centre lymphoma CT scan (3 revisions)
  18. Primary cutaneous follicle centre lymphoma Interventions (3 revisions)
  19. Primary cutaneous follicle centre lymphoma X-ray (3 revisions)
  20. Primary cutaneous follicle centre lymphoma cost-effectiveness of therapy (3 revisions)
  21. Primary cutaneous follicle centre lymphoma future or investigational therapies (3 revisions)
  22. Primary hyperaldosteronism Risk Factors (3 revisions)
  23. Primary hyperaldosteronism Secondary Prevention (3 revisions)
  24. Primary hyperaldosteronism case study one (3 revisions)
  25. Primary hyperaldosteronism cost-effectiveness of therapy (3 revisions)
  26. Primary mediastinal large B-cell lymphoma historical perspective (3 revisions)
  27. Primary progressive aphasia (3 revisions)
  28. Primary sclerosing cholangitis cost-effectiveness of therapy (3 revisions)
  29. Primary sclerosing cholangitis future or investigational therapies (3 revisions)
  30. Principal investigator role (3 revisions)
  31. Pristinamycin (3 revisions)
  32. ProMACE-CytaBOM regimen (3 revisions)
  33. ProMACE-MOPP regimen (3 revisions)
  34. Probenecid (patient information) (3 revisions)
  35. Procardia XL (3 revisions)
  36. Prochlorperazine (3 revisions)
  37. Procollagen peptidase (3 revisions)
  38. Proctalgia fugax historical perspective (3 revisions)
  39. Proctitis endoscopy (3 revisions)
  40. Proctitis history and symptoms (3 revisions)
  41. Proctitis natural history, complications and prognosis (3 revisions)
  42. Proctitis overview (3 revisions)
  43. Proctitis primary prevention (3 revisions)
  44. Prodynorphin (3 revisions)
  45. Profenamine (3 revisions)
  46. Profilin 1 (3 revisions)
  47. Progabide (3 revisions)
  48. Progeria interventions (3 revisions)
  49. Progeria other diagnostic studies (3 revisions)
  50. Proglumetacin (3 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"